-
2026 Pujiang Urological Oncology Academic Conference丨Chunguang Ma: Immunotherapy Opens a New Era in Adjuvant Treatment for Urothelial Carcinoma—From a Shift in Perioperative Concepts to Precision Whole-Course Management
The 2026 Pujiang Urological Oncology Academic Conference was held in Shanghai, bringing together experts from China and abroad to discuss standardized diagnosis and treatment, innovations in surgical techniques, and advances in precision medicine in urological oncology. In recent years, immunotherapy and antibody-drug conjugates (ADCs) have progressively moved from the treatment of advanced urothelial carcinoma (UC)…
-
Professor Yongmei Yin: Advancing Precision Oncology from Concept to Clinical Practice — Key Insights from the 2026 “Renyi” Clinical Research Conference on Innovative Anticancer Drugs
From July 31 to August 2, 2026, the 2026 “Renyi” Clinical Research Conference on Innovative Anticancer Drugs was held in Nanjing. The conference was part of the academic events celebrating the 90th anniversary of Jiangsu Province Hospital (the First Affiliated Hospital of Nanjing Medical University and Jiangsu Women and Children’s Medical Center). Under the theme…
-
2026 Northern Breast Cancer Salon · Getting to the Bottom of It丨Professors Wenyan Chen and Ning Xie: Treatment Options for HER2-Positive Metastatic Breast Cancer After Failure of H-Based Therapy
The Northern Breast Cancer Salon was recently held successfully in Qingdao. The meeting focused on the latest advances and clinical hot topics in breast cancer, bringing together numerous experts and scholars for in-depth academic exchange. During the meeting, Professor Wenyan Chen of Nanchang People’s Hospital and Professor Ning Xie of Hunan Cancer Hospital respectively shared…
-
2026 Northern Breast Cancer Salon · Time & Memory丨Professor Guohong Song: Breaking New Ground and Advancing Further — The Evolution of HER2-Positive Breast Cancer Treatment and the New Treatment Landscape in the ADC Era
Over the past two decades, the treatment of HER2-positive breast cancer has undergone a dramatic transformation, evolving from targeted therapy to the era of antibody-drug conjugates (ADCs), with substantial improvements in patient survival and prognosis. Recently, the Northern Breast Cancer Salon was successfully held in Qingdao. During the meeting, Oncology Frontier interviewed Professor Guohong Song…
-
2026 Northern Breast Cancer Salon · Time & Memory | Professor Yongmei Yin: Seeing the Subtle to Foresee the Far — The Evolution of Precision Diagnosis and Treatment in Breast Cancer from Molecular Subtyping to Gene-Guided Therapy
Breast cancer is the most commonly diagnosed malignancy among women worldwide. Looking back over the past century, its diagnosis and treatment have evolved from viewing breast cancer primarily as a locoregional disease treated mainly with surgery, to recognizing its systemic nature and developing systemic therapies, and ultimately to the clinical adoption of molecular subtype-based treatment.…
-
2026 Northern Breast Cancer Salon | Professor Jin Yang: Immunotherapy Combined with ADCs Reshapes the Treatment Landscape of Advanced Breast Cancer, While Updated Consensus Guides the Path Toward Precision Treatment
Recently, the Northern Breast Cancer Salon was successfully held in Qingdao, bringing together leading experts and scholars to discuss the latest advances and clinical hot topics in breast cancer. During the meeting, Professor Jin Yang of the First Affiliated Hospital of Xi’an Jiaotong University delivered a systematic and insightful presentation on controversial issues surrounding immunotherapy…
-
10th Yunling Breast Cancer Conference | Professor Cexi Chen: Looking Ahead to the Future of Translational Medicine — ADCs, PROTACs, and Organoids as Three Key Priorities to Advance High-Level Breast Cancer Research
: Breast cancer is one of the most active fields in oncology research and translational medicine. From HER2-targeted therapy to individualized treatment guided by molecular subtyping, numerous basic research discoveries have profoundly transformed clinical practice. During the 10th Yunling Breast Cancer Conference, held in Kunming on August 21–22, 2026, Professor Cexi Chen of Yunnan Cancer…
-
10th Yunling Breast Cancer Conference | Professor Jianyun Nie: Standardization as the Foundation for Regional Diagnosis and Treatment, Precision Driving the Evolution of Breast Surgery
Since its establishment in 2016, the Yunling Breast Cancer Conference has been successfully held for ten consecutive editions. It has evolved from a learning and exchange platform initially serving breast cancer professionals in Yunnan Province into a major academic meeting with influence across Southwest China and nationally. The 10th Yunling Breast Cancer Conference was held…
Connecting Medical Expertise through Media